Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Cell Banking Outsourcing Market Growth Performance Trended Historically, And What Lies Ahead?

The market size for cell banking outsourcing has experienced swift growth in the last few years. It is projected to escalate from $11.19 billion in 2024 to $12.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.2%. The growth observed during the historic period can be linked to a surge in chronic illnesses, an uptick in government initiatives, enhanced regulatory support and guidelines, and an increase in banking services establishments.

What Is the Forecast for the Cell Banking Outsourcing Market Size Through 2029?

In the approaching years, the market size for cell banking outsourcing is anticipated to experience swift expansion. The projection reveals an upsurge to $22.39 billion in 2029, with a compound annual growth rate (CAGR) of 14.8%. Factors contributing to the growth during the predicted period include an escalating adoption of cell-based products, increased demand for monoclonal antibodies, a rising trend towards stem cell therapies, an expanding geriatric population, and an increased reliance on cell-based therapies. Significant trends anticipated during the forecast period encompass product innovations, advancements in technology, increased investment in research and development, and partnership initiatives between biotech companies and specialized cell banking services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp

What are the Key Market Players in Cell Banking Outsourcing Market and How They’re Evolving?

Major companies operating in the cell banking outsourcing market are LabCorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd., Perfectus Biomed Limited, BioStorage Technologies Inc.

What Are the Primary Growth Drivers in the Cell Banking Outsourcing Market?

An increase in chronic diseases is anticipated to spur the expansion of the cell banking outsourcing market. Conditions that persist for a long duration, typically evolving gradually, are known as chronic diseases. Numerous factors contribute to the surge in chronic diseases, such as shifts in lifestyle, increasing age demographics, and genetic proclivities. Cell banking outsourcing significantly contributes to research and development initiatives for chronic diseases, offering access to specialized skills, resources, and infrastructure that may not exist internally. For example, data from the Department of the Treasury, an Australian national treasury and financial department, in July 2023 reveals that in 2020–21, almost half of the Australian population across all age groups (46.6%) were battling one or more chronic diseases, while nearly one in five (18.6%) had two or more ongoing conditions. Consequently, the escalating burden of chronic diseases is propelling the growth of the cell banking outsourcing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15754&type=smp

What Are the Leading Segments in the Global Cell Banking Outsourcing Industry?

The cell banking outsourcing market covered in this report is segmented –

1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking

2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking

3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation

Subsegments:

1) By Master Cell Banking: Human Master Cell Bank, Animal Master Cell Bank

2) By Working Cell Banking: Human Working Cell Bank, Animal Working Cell Bank

3) By Viral Cell Banking: Virus Bank For Vaccine Production, Viral Vector Bank For Gene Therapy, Adenovirus Bank

What Are the Key Market Trends in the Cell Banking Outsourcing Industry?

Leading firms in the cell banking outsourcing sector are concentrating on creating cutting-edge technological solutions like single-cell potency characterization platforms to offer accurate, in-depth analysis of individual cell potency. Such platforms utilize advanced techniques to evaluate and quantify the potency and functionality of individual cells within a cell group. For example, in January 2024, biotech firm Cellply Srl, which is based in Italy, introduced its principal product, VivaCyte. This is an all-encompassing single-cell potency characterization platform that combines potency analysis with immunophenotyping to expedite cell therapy research and development. VivaCyte is a fully independent platform with single-cell resolution, engineered to minimize development duration, expenses, and risks through swift, exhaustive characterization of the intricate functionality and operation mechanism of viable cellular immunotherapies. The platform facilitates speedy testing of numerous cell therapy contenders from a variety of process alternatives against different target tumor cells. This ensures consistent immune cell characterization and single-cell functional characterization, vastly faster than existing analytical tools.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report

What Is the Regional Outlook for the Cell Banking Outsourcing Market?

North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15754

This Report Delivers Insight On:

1. How big is the cell banking outsourcing market, and how is it changing globally?

2. Who are the major companies in the cell banking outsourcing market, and how are they performing?

3. What are the key opportunities and risks in the cell banking outsourcing market right now?

4. Which products or customer segments are growing the most in the cell banking outsourcing market?

5. What factors are helping or slowing down the growth of the cell banking outsourcing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model